 | OncoCyte Corporation | |||
| NCM : OCX || Location: United States | ||||
$2.48+0.04 (+1.64%) |
0.02 M | 2.41 - 2.58 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.233 M |
| March 28, 2024 | 0.179 M |
| March 15, 2024 | 0.178 M |
| Feb. 29, 2024 | 0.178 M |
| Feb. 15, 2024 | 0.183 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -1.02 | -0.81 | 20.40% |
| 06/30/2023 | -1.31 | -1.07 | 18.51% |
| 03/31/2023 | -1.86 | 0.40 | 121.52% |
| 12/31/2022 | -0.09 | -0.40 | -344.40% |
| 09/30/2022 | -0.11 | -0.08 | 27.30% |
OCX Basic Data
| Sector | Healthcare | Industry | Diagnostics & Research |
| Shares Outstanding | 13.338M | Shares Float | 0.084M |
| Short Float | 0.233M | Market Cap | 32.54M |
| Institution ownership | 86.16% | Insider ownership | 20.643% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.37 | Forward EPS | -1.75 |